Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 2102015Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2026 onlyCareer claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$493.9K
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#22,665
By linked amount among FY2026 PIs
Earliest Year Loaded
2026
ScienceDex PI coverage
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2026): $493.9K in linked award amounts across 1 award record · Award-linked rank #22665.
FY2026 award records by amount
NIH award records listing George A O'Doherty as a PI. Multi-PI records show the full award amount for context.
- 1R21AI199146-01R21Development of next generation spectinomycin analogs that evade modifying enzyme-based resistance and show enhanced potency against multidrug-resistant pathogens.$493.9Kaward amount
Award organization
Organizations that administered FY2026 awards listing George A O'Doherty as a PI.
FY2026 award administered by Beth Israel Deaconess Medical Center (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2026First NIH AwardBeth Israel Deaconess Medical Center
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as George A O'Doherty.